English (UK)
中文版Betty Huang
Top tier Pharmaceutical company in China with leading position in cardiovascular, diabetes, women healthcare, oncology.
Bayer
Head of BD China/APDawei Jiang
China top 3 pharma company in both commercialization and manufacturing sales. Dual listed on HK and Shanghai stock exchange market .
Shanghai Pharma Holding
Sr. BD ManagerWei Li
Jianmin Group (600976.SSE) is an integrated pharmaceutical company with a major focus on pediatric product development, manufacture, and marketing. Founded in 1953, headquartered in Wuhan, the largest city in Central China, its history can be traced back to 17th century. Jianmin has been a famous pharma brand in China among children and their parents for generations. Its rich pediatric portfolio ranges from nutrition, hematology, respiratory, digestive, CNS, to infections and common cold as well.
Jianmin Pharma Group
Head of Business DevelopmentAllen Li
Pregene is a world-leading cell and gene therapy company. Pregene is committed to develop innovative gene and cell therapy technologies and create reliable products from continued innovation and R&D. And pregene can provide CDMO service.
Shenzhen Pregene Biopharma Co., ltd
BD DirectorChunlin Li
Kelun-Biotech Biopharmaceutical is a subsidiary of Kelun Pharmaceutical Group established in 2016
Looking for antibody and samall molecular out-license and in-license
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd
BD btlichl@kelun.comVincent Liao
A listed and famous Chinese pharmaceutical company and also the main profit center of CR pharmaceutical Group which is the 2nd largest pharmaceutical group in China. The company has rich experiences in collaboration with multinational companies such as Sanofi, Takeda, Roche, Bailey and Novo Nordisk and so on. We are looking forward to cooperating with partners whose assets could meet the unmet medical needs and whom desire to explore China market.
China Resources Sanjiu
Senior Investment and BD managerJasmine Lien
Nuance Biotech (Shanghai) Co. Ltd was founded in 2014.
Leading China based biotech company focussed on commercial, regulatory and development stage assets.
Nuance is directed by a world class board of directors and managed by an experienced China based management team with a strong track record. Backed a leading global tier 1 investor with more than USD 1 billion under management in China – Matrix Partners. The company strategy and approach allows for a highly scalable commercial and drug development model i.e. ability to run multiple initiatives.
Leading China based biotech company focussed on commercial, regulatory and development stage assets.
Nuance is directed by a world class board of directors and managed by an experienced China based management team with a strong track record. Backed a leading global tier 1 investor with more than USD 1 billion under management in China – Matrix Partners. The company strategy and approach allows for a highly scalable commercial and drug development model i.e. ability to run multiple initiatives.
Responsive Web Design powered by 